News

COVID-19 RESEARCH SUPPORT

June 10, 2020

To support the world-wide urgent need for a vaccine against COVID-19 disease, Var2 Pharmaceuticals and VarCT Diagnostics have made their protein engineering and production pipelines available to a joint vaccine program ongoing at the University of Copenhagen in collaboration with AdaptVac (www.adaptvac.com) and Bavarian Nordic (OMX: BAVA, OTC: BVNRY). Read

Read More

VAR2 PHARMACEUTICALS AWARDED THE SIGMAMILLIPORE BIOTECH GRANT 2020

May 29, 2020

Var2 Pharmaceuticals has been selected as the European winner of the 2020 Advance Biotech Grant Program (SigmaMillipore). VAR2 Pharmaceuticals was chosen for its development of a promising novel pre-clinical cancer drug-conjugate treatment with the potential to treat multiple types of human adult and childhood solid tumors.   VAR2 Pharmaceuticals ApS

Read More

VAR2 Pharmaceuticals ApS

Ole Maaløes Vej 3
DK-2200 Copenhagen N
CVR: 34621942

T: +45 78 70 19 00